中新网北京5月2日电 (记者 欧阳开宇)“随着生物医学的发展，当前的乳腺癌治疗已逐渐步入分类治疗的阶段，患者可通过检测及早明确疾病类型，以获得针对性的治疗方案。”这是中国医学科学院肿瘤医院教授徐兵河所得出的结论。

中新网北京5月2日电 (The reporter OuYangKaiYu)"With the development of biomedicine,The current treatment of breast cancer has been gradually into the classification stage of treatment,Patients can be through the detection of early disease type,To get targeted treatment."This is a professor at the Chinese academy of medical sciences tumor hospital Xu Bing river the conclusion.

　　徐兵河在日前举行的“相信生命的奇迹—乳腺癌患者支持行动”启动式上以HER2阳性乳腺癌举例说，患者一旦明确疾病类型将有助于采取个体化的靶向治疗方案，并最终战胜这种疾病。

徐兵河在日前举行的"Believe the miracle of life - in patients with breast cancer support action"Operated on with HER2 positive breast cancer, for example,Once clear disease in patients with type will help to adopt individualized targeted therapies,And ultimately triumph over the disease.

　　“但令人遗憾的是，有调查显示，仅13%的患者对HER2检测有正确的认知，约10%的患者对靶向治疗有了解，但认知有限；而这些比例即使是在HER2阳性乳腺癌患者中，也仅为14%和13%。”徐兵河说。

"But it is a pity,Have a survey,Only 13% of the patients have right cognition on HER2 detection,About 10% of the patients is know for targeted therapy,But cognitive co., LTD.;The ratio even in patients with HER2 positive breast cancer,Only 14% and 13%."Xu Bing river said.

　　中国抗癌协会癌症康复工作委员会主任委员史安俐说，受制于对疾病分型及检测缺少了解，近年来，乳腺癌患者错失治疗良机的情况仍时有发生，而且我们发现认知误区还会造成患者心理压力过大，引起过度治疗。

中国抗癌协会癌症康复工作委员会主任委员史安俐说,Subject to the disease classification and testing a lack of understanding,In recent years,Breast cancer patients who missed treatment of opportunities still happen,And we found that patients with cognitive error will cause mental stress,Cause excessive treatment.

　　公开资料显示，乳腺癌是威胁女性健康的第一恶性肿瘤，中国每年有16.9万患者被新确诊为乳腺癌。专家们呼吁，应提升公众及患者对于乳腺癌防治及检测的认知水平，鼓励更多患者勇敢面对疾病，接受针对性的治疗。(完)

公开资料显示,Breast cancer is a threat to women's health first malignant tumor,China each year, 169000 patients were newly diagnosed with breast cancer.The experts called for,Should raise the public and patients of breast cancer prevention and detection of cognitive level,Encourage more brave in the face of disease patients,Targeted therapy.(After the)